secwatch / observer
8-K filed July 31, 2023, 7:59 PM ET ticker PETS CIK 0001040130
earnings confidence high sentiment negative materiality 0.65

PetMed Express Q1 net sales $78.2M (+11.5% YoY); net loss $(0.9)M; declares $0.30 dividend

PETMED EXPRESS INC

2024-Q1 EPS reported -$0.04 revenue$78,244,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.99

PETMED EXPRESS INC reported first quarter ended June 30, 2023 results: revenue $78.2 million, net income Net loss for the quarter ended June 30, 2023 was $(0.9) million, EPS $(0.04) per diluted share.

Period
first quarter ended June 30, 2023
Revenue
$78.2 million
Net income
Net loss for the quarter ended June 30, 2023 was $(0.9) million
EPS
$(0.04) per diluted share
Result
reported results
Exact text from the filing
Health Expert TM , today announced its financial results for its first quarter ended June 30, 2023. Quarterly Highlights • Net sales for the quarter ended June 30, 2023, were $78.2 million, compared to $70.2 million for the first quarter in the prior year, an increase of 11.5%. • PetMeds reported an increase in new customers of 25% year over year for the quarter
View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR
accession 0001040130-23-000049
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.